Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse TREM-1 Antibody, R&D Systems™

Rat Monoclonal Antibody has been used in 7 publications
Supplier: R&D Systems MAB1187100
This item is not returnable.
View return policy
Description
TREM1 Monoclonal specifically detects TREM1 in Mouse samples. It is validated for Western Blot, Flow Cytometry, Agonist Activity, Immunocytochemistry, CyTOF-ready.Specifications
TREM1 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CD354, CD354 antigen, TREM1, TREM-1Triggering receptor expressed on monocytes 1, triggering receptor expressed on myeloid cells 1, triggering-receptor TREM1 | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
54210 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Western Blot, Flow Cytometry, Agonist Activity, Immunocytochemistry, CyTOF | |
174031 | |
Western Blot 1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Agonist Activity, Immunocytochemistry 8-25 ug/mL, CyTOF-ready | |
Q9JKE2 | |
TREM1 | |
Mouse myeloma cell line NS0-derived recombinant mouse TREM-1 Ala21-Ser202 Accession # Q9JKE2 | |
100 μg | |
Primary | |
Detects mouse TREM-1 in direct ELISAs and Western blots. In Western blots, no cross-reactivity with recombinant mouse TREM-2B, recombinant human (rh) TREM-1, or rhTREM-2 is observed. | |
Mouse | |
Supernatant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction